| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 07/08/2017 | 21:41 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 03/08/2017 | 18:15 | Edgar (US Regulatory) | Amended Report of Foreign Issuer (6-k/a) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 31/03/2017 | 15:36 | Edgar (US Regulatory) | Annual and Transition Report (foreign Private Issuer) (20-f) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 21/03/2017 | 21:18 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 14/02/2017 | 17:47 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 03/01/2017 | 18:09 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 03/01/2017 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 21/12/2016 | 20:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 21/12/2016 | 20:40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 21/12/2016 | 15:43 | Edgar (US Regulatory) | (25) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 19/12/2016 | 22:30 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 09/12/2016 | 23:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the... | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 01/12/2016 | 13:01 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 23/11/2016 | 04:34 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 02/11/2016 | 21:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 27/10/2016 | 21:49 | GlobeNewswire Inc. | Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 04/08/2016 | 13:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 26/07/2016 | 23:00 | GlobeNewswire Inc. | Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 31/05/2016 | 22:05 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 13/05/2016 | 23:13 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(1) (424b1) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 12/05/2016 | 13:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 29/04/2016 | 20:52 | Edgar (US Regulatory) | Securities Registration (foreign Private Issuer) (f-1/a) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 22/04/2016 | 13:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 18/04/2016 | 22:05 | GlobeNewswire Inc. | Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 15/04/2016 | 22:31 | Edgar (US Regulatory) | Securities Registration (foreign Private Issuer) (f-1) | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 31/03/2016 | 13:00 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 10/03/2016 | 01:46 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 18/02/2016 | 14:00 | GlobeNewswire Inc. | Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016 | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 20/01/2016 | 19:01 | GlobeNewswire Inc. | UPDATE -- Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares... | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |
| 19/01/2016 | 23:15 | GlobeNewswire Inc. | Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Captial Fund to Purchase Ordinary Shares | USOTC:PARNF | Parnell Pharmaceuticals Holdings Ltd (CE) |